share_log

PhaseBio Pharmaceuticals Says On Oct. 25, 2022 Co. Received Notice From Nasdaq Stating It Has Determined That Co.'s Securities Will Be Delisted From Nasdaq

Benzinga Real-time News ·  Oct 31, 2022 17:31
PhaseBio Pharmaceuticals Says On Oct. 25, 2022 Co. Received Notice From Nasdaq Stating It Has Determined That Co.'s Securities Will Be Delisted From Nasdaq
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment